Search | IOVS | ARVO Journals

Showing 1 – 20 of 37

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina May 2019

Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS

PDF

Douglas A. Jabs; Mark L. Van Natta; Garrett Trang; Norman Jones; Jeffrey M. Milush; Ryan Cheu; Nichole R. Klatt; Jeong Won Pak; Ronald P. Danis; Peter W. Hunt
TAGS: acquired immunodeficiency syndrome, inflammation, linear regression, retinal vascular caliber
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2218-2225. doi: 10.1167/iovs.18-26070

Includes: Supplemental Content

Immunology and Microbiology May 2019

Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS

PDF

Gary N. Holland; Mark L. Van Natta; David T. Goldenberg; Rory Ritts Jr; Ronald P. Danis; Douglas A. Jabs; for the Studies of Ocular Complications of AIDS Research Group
TAGS: acquired immunodeficiency syndrome, cytomegalovirus retinitis, immunologic deficiency syndromes
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):1853-1862. doi: 10.1167/iovs.18-26517

ARVO Annual Meeting Abstract July 2018

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Elizabeth A Sugar; Janet A Holbrook; Alyce E Burke; Glenn J Jaffe; Albert T Vitale; Janet L. Davis; Douglas A Jabs

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):417. doi:

ARVO Annual Meeting Abstract July 2018

Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome

Douglas A Jabs; Mark L. Van Natta; Jeong W Pak; Ronald P Danis; Peter Hunt

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5564. doi:

Retina February 2018

Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome

PDF

Douglas A. Jabs; Mark L. Van Natta; Jeong Won Pak; Ronald P. Danis; Peter W. Hunt
TAGS: acquired immunodeficiency syndrome, age-related macular degeneration, retinal vasculature, retinal vascular caliber
Invest. Ophthalmol. Vis. Sci.. 2018; 59(2):904-908. doi: 10.1167/iovs.17-23334

ARVO Annual Meeting Abstract June 2017

Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome

Douglas A Jabs; Mark L Van Natta; Ronald P Danis; Jeong Pak; Peter Hunt

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1623. doi:

ARVO Annual Meeting Abstract September 2016

Lessons on immune evasion in the retina by viruses secondary to AIDS

Douglas A. Jabs

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Agreement among Uveitis Experts on Diagnosis: The SUN Classification Criteria Project Experience

Douglas A. Jabs

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome

Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald P Danis; Studies of the Ocular Complications of AIDS Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1409. doi:

ARVO Annual Meeting Abstract June 2015

Dissociations of fluocinolone acetonide implants in the MUST study

Jennifer E Thorne; Elizabeth Sugar; Alyce Burke; Albert T Vitale; Douglas A Jabs; Janet T. Holbrook; Multicenter Uveitis Steroid Treatment (MUST)

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3108. doi:

ARVO Annual Meeting Abstract June 2015

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

John H Kempen; Michael M Altaweel; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3209. doi:

ARVO Annual Meeting Abstract June 2015

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Michael M Altaweel; John H Kempen; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5774. doi:

ARVO Annual Meeting Abstract June 2015

Relationships between HIV-related Neuroretinal Disorder and Measures of Vision-Specific Quality of Life among People with AIDS

Davin Ashraf; Kevin Patrick May; Gary N Holland; Mark L Van Natta; Albert Wu; Jennifer E Thorne; Douglas A Jabs; Studies of the Ocular Complications of AIDS (SOCA) Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5777. doi:

ARVO Annual Meeting Abstract April 2014

Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis

Srishti Kothari; Maxwell Pistilli; C Stephen Foster; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; John H Kempen; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):844. doi:

ARVO Annual Meeting Abstract April 2014

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Elizabeth A Sugar; Janet T Holbrook; John H Kempen; Alyce E Burke; Lea T Drye; Jennifer E Thorne; Thomas A Louis; Douglas A Jabs; Michael M Altaweel; Kevin Frick; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5796. doi:

ARVO Annual Meeting Abstract April 2014

Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis

Ebenezer Daniel; Maxwell Pistilli; H Nida Sen; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; John H Kempen; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6031. doi:

ARVO Annual Meeting Abstract April 2014

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Douglas A Jabs; Mark L Van Natta; Michael M Altaweel; James P Dunn; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6033. doi:

ARVO Annual Meeting Abstract April 2014

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6036. doi:

ARVO Annual Meeting Abstract March 2012

Risk Of Cataract In Persons With Acquired Immune Deficiency Syndrome And Cytomegalovirus Retinitis

Elizabeth A. Sugar; Alice T. Lyon; Richard A. Lewis; Douglas A. Jabs; Murk-Hein Heinemann; James P. Dunn; John H. Kempen; Studies of Ocular Complications of AIDS Research Group

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6218. doi:

ARVO Annual Meeting Abstract March 2012

Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study

Jennifer E. Thorne; Anthony Gregory; Ebenezer Daniel; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6253. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Association of Systemic Inflammation With Retinal Vascular Caliber in Patients With AIDS

Relationship Between Opacity of Cytomegalovirus Retinitis Lesion Borders and Severity of Immunodeficiency Among People With AIDS

Dissociations of the fluocinolone acetonide implant: experience from long-term follow-up during the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Association of Age-related Macular Degeneration with Retinal Vascular Caliber in Patients with the Acquired Immunodeficiency Syndrome

Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome

Incidence of Age-Related Macular Degeneration in Patients with the Acquired Immune Deficiency Syndrome

Lessons on immune evasion in the retina by viruses secondary to AIDS

Agreement among Uveitis Experts on Diagnosis: The SUN Classification Criteria Project Experience

Prevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome

Dissociations of fluocinolone acetonide implants in the MUST study

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Relationships between HIV-related Neuroretinal Disorder and Measures of Vision-Specific Quality of Life among People with AIDS

Risk of Elevated Intraocular Pressure (IOP) in Pediatric Non-infectious Uveitis

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Risk Of Cataract In Persons With Acquired Immune Deficiency Syndrome And Cytomegalovirus Retinitis

Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study

To View More...

You must be signed into an individual account to use this feature.